La esquizofrenia es una enfermedad mental grave con un 0.6-0.8% de prevalencia mundial, que se inicia durante la adolescencia o adultez temprana, y presenta una combinación heterogénea de síntomas clasificados en positivos, desorganizados, negativos y cognitivos. Los pacientes muestran una pérdida de contacto con la realidad,...
-
August 7, 2024 (v1)PublicationUploaded on: August 8, 2024
-
November 9, 2022 (v1)Publication
Reelin is an extracellular matrix glycoprotein reduced in brain regions (the prefrontal cortex and the hippocampus) of patients with schizophrenia. There are diverse rodent models of schizophrenia that mimic patient symptoms based on various causal theories; however, likely shared reelin alterations have not yet been systematically assessed in...
Uploaded on: December 4, 2022 -
December 1, 2021 (v1)Publication
Presenilins (PS) form the active subunit of the gamma-secretase complex, which mediates the proteolytic clearance of a broad variety of type-I plasma membrane proteins. Loss-of-function mutations in PSEN1/2 genes are the leading cause of familial Alzheimer's disease (fAD). However, the PS/gamma-secretase substrates relevant for the neuronal...
Uploaded on: December 4, 2022 -
July 30, 2024 (v1)Publication
Alzheimer's disease (AD) is characterized by memory impairments and age-dependent synapse loss. Experimental and clinical studies have shown decreased expression of the glutamatergic protein Neuroligin-1 (Nlgn1) in AD. However, the consequences of a sustained reduction of Nlgn1 are unknown. Here, we generated a knockin mouse that reproduces the...
Uploaded on: July 31, 2024